Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets
Cash	$ 32	$ 76
Prepaid expenses	47	120
Total current assets	79	196
Total assets	79	196
Current liabilities
Accounts payable	2,397	2,309
Due to related parties	26	46
Accrued expenses	4,373	3,110
Accrued dividends	498	5,477
Term loans, net	7,333	5,677
Convertible notes payable, net	1,252	986
Derivative liability	6,386	7,697
Total current liabilities	22,265	25,302
Total liabilities	22,265	25,302
Commitments and contingencies (Note 9)
Stockholders’ deficit
Preferred stock, $0.01 par value; 100,000 shares authorized
Common stock, $0.006 par value; 180,000,000 shares authorized, 3,160,877 and 853,946 shares issued and outstanding as of December 31, 2022, and 2021, respectively	19	5
Additional paid-in capital	33,548	27,906
Accumulated deficit	(55,751)	(53,017)
Treasury Stock (5,594 shares)	(2)
Total stockholders’ deficit	(22,186)	(25,106)
Total liabilities and stockholders’ deficit	79	196
Series C Convertiable Preferred Stock [Member]
Stockholders’ deficit
Preferred stock, $0.01 par value; 100,000 shares authorized
Series D Convertiable Preferred Stock [Member]
Stockholders’ deficit
Preferred stock, $0.01 par value; 100,000 shares authorized
Series E Convertiable Preferred Stock [Member]
Stockholders’ deficit
Preferred stock, $0.01 par value; 100,000 shares authorized
Series F Convertiable Preferred Stock [Member]
Stockholders’ deficit
Preferred stock, $0.01 par value; 100,000 shares authorized
Series G Convertiable Preferred Stock [Member]
Stockholders’ deficit
Preferred stock, $0.01 par value; 100,000 shares authorized